Comparative Pharmacology
Head-to-head clinical analysis: FURACIN versus SSD.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FURACIN versus SSD.
FURACIN vs SSD
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nitrofurazone is a nitrofuran derivative that acts as a bactericidal agent by inhibiting bacterial enzymes involved in carbohydrate metabolism. It undergoes reduction by bacterial nitroreductases to reactive intermediates that damage DNA and other macromolecules.
Silver sulfadiazine acts by releasing silver ions that bind to microbial DNA and cell membranes, inhibiting bacterial replication and disrupting cell wall synthesis. It also inhibits the folate synthesis pathway via sulfadiazine.
Topical: Apply to affected area 2-3 times daily. For urinary tract infection (oral, not available in US): 50-100 mg orally 4 times daily.
Apply 1/16 inch thick layer to affected area once or twice daily; maintain continuous coverage.
None Documented
None Documented
Terminal elimination half-life is 3-7 hours in adults with normal renal function; may be prolonged in renal impairment.
Terminal half-life: 2-4 hours in adults with normal renal function; clinically, dosing interval is every 6-8 hours due to concentration-dependent bactericidal activity.
Primarily renal (approximately 40-60% unchanged drug), with minor biliary and fecal elimination (~5-10%).
Renal excretion of unchanged drug (approximately 70-80%) and hepatic metabolism to inactive metabolites (20-30%); less than 2% excreted fecally.
Category C
Category C
Topical Antibacterial
Topical Antibacterial